Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Patrick W. Sullivan, Abhishek Kavati, Vahram H. Ghushchyan, Miguel J. Lanz, Benjamin Ortiz, Diego J. Maselli & Jason LeCocq. (2020) Impact of allergies on health-related quality of life in patients with asthma. Journal of Asthma 57:11, pages 1263-1272.
Read now
Read now
Patrick W. Sullivan, Miguel J. Lanz, Vahram H. Ghushchyan, Abhishek Kavati, Jason LeCocq, Benjamin Ortiz & Diego J. Maselli. (2020) Healthcare resource utilization, expenditures, and productivity in patients with asthma with and without allergies. Journal of Asthma 57:9, pages 959-967.
Read now
Read now
Philippe Moingeon & Linda Cox. (2016) Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America. Expert Review of Clinical Immunology 12:6, pages 617-623.
Read now
Read now
Articles from other publishers (7)
W. Gerald Teague, Ahmar Iqbal, Yao Ding, Bradley E. Chipps & James L. Zazzali. (2021) The Added Burden of Allergen Sensitization Among Children with Severe or Poorly Controlled Asthma. The Journal of Allergy and Clinical Immunology: In Practice 9:2, pages 853-861.e5.
Crossref
Crossref
Ioana Agache, Claudio Rocha, Jessica Beltran, Yang Song, Margarita Posso, Ivan Solà, Pablo Alonso‐Coello, Cezmi Akdis, Mubeccel Akdis, Giorgio W. Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Stefano Del Giacco, Thomas Eiwegger, Davide Firinu, James E. Gern, Eckard Hamelmann, Nicola Hanania, Mika Mäkelä, Irene Hernández Martín, Parameswaran Nair, Liam O'Mahony, Nikolaos G. Papadopoulos, Alberto Papi, Hae‐Sim Park, Luis Pérez de Llano, Santiago Quirce, Joaquin Sastre, Mohamed Shamji, Jurgen Schwarze, Carlos Canelo‐Aybar, Oscar Palomares & Marek Jutel. (2020) Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Allergy 75:5, pages 1043-1057.
Crossref
Crossref
Ane Johannessen, Marianne Lønnebotn, Lucia Calciano, Bryndis Benediktsdóttir, Randi Jacobsen Bertelsen, Lennart Bråbäck, Shyamali Dharmage, Karl A. Franklin, Thorarinn Gislason, Mathias Holm, Christer Janson, Deborah Jarvis, Rain Jõgi, Jeong-Lim Kim, Jorunn Kirkeleit, Caroline Lodge, Andrei Malinovschi, Jesus Martinez-Moratalla, Roy Miodini Nilsen, Antonio Pereira-Vega, Francisco Gómez Real, Vivi Schlünssen, Simone Accordini & Cecilie Svanes. (2020) Being overweight in childhood, puberty, or early adulthood: Changing asthma risk in the next generation?. Journal of Allergy and Clinical Immunology 145:3, pages 791-799.e4.
Crossref
Crossref
C. C. Loureiro, L. Amaral, J. A. Ferreira, R. Lima, C. Pardal, I. Fernandes, L. Semedo & A. Arrobas. (2018) Omalizumab for Severe Asthma: Beyond Allergic Asthma. BioMed Research International 2018, pages 1-10.
Crossref
Crossref
Cecilia Sierra-Heredia, Michelle North, Jeff Brook, Christina Daly, Anne Ellis, Dave Henderson, Sarah Henderson, Éric Lavigne & Tim Takaro. (2018) Aeroallergens in Canada: Distribution, Public Health Impacts, and Opportunities for Prevention. International Journal of Environmental Research and Public Health 15:8, pages 1577.
Crossref
Crossref
Xuehua Ke, Abhishek Kavati, Debra Wertz, Qing Huang, Liya Wang, Vincent J. Willey, Judith J. Stephenson, Benjamin Ortiz, Reynold A. PanettieriJr,Jr, & Jonathan Corren. (2018) Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With Omalizumab. Clinical Therapeutics 40:7, pages 1140-1158.e4.
Crossref
Crossref
A. Linneberg, K. Dam Petersen, J. Hahn-Pedersen, E. Hammerby, N. Serup-Hansen & N. Boxall. (2016) Burden of allergic respiratory disease: a systematic review. Clinical and Molecular Allergy 14:1.
Crossref
Crossref